Sales rise 9.38% to Rs 2245.37 crore
Net profit of Ipca Laboratories rose 37.95% to Rs 248.14 crore in the quarter ended December 2024 as against Rs 179.88 crore during the previous quarter ended December 2023. Sales rose 9.38% to Rs 2245.37 crore in the quarter ended December 2024 as against Rs 2052.85 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales2245.372052.85 9 OPM %20.6216.12 -PBDT466.38319.93 46 PBT367.92220.43 67 NP248.14179.88 38Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content


